A shift in USFDA regulations, demand to diversify their product portfolio, and need to reduce dependence on traditional generics, are some reasons for the trend, reports businessline.
Drugmakers are urging the Trump administration and European Union officials to exclude medical goods from expanding tariff ...
The Trump administration's decision to pause U.S. foreign aid has "substantially disrupted" supply of HIV treatments in eight ...
Generic drugmakers and hospital pharmacists warn that added financial pressure from tariffs could strain the nation's generic drug supplies.
Driven by innovation, research, and a deep commitment to social responsibility, Pharmalat has grown from a small, family-run ...
K reports of America’s largest pharmaceutical companies show that they continue to avoid paying much, if any, U.S. corporate income tax.
Despite a rocky start for many drugmakers at the start of last year, 2024’s fourth quarter saw just two of the top 25 global ...
Takeda Pharmaceutical has a robust drug discovery pipeline to meet future clinical demand. Check out the upside and downside ...
Pharmaceutical consultants apply their comprehensive expertise in different areas to accelerate the drug development process.
Teva Pharmaceutical Industries Limited ( NYSE: TEVA) Barclays 27th Annual Global Healthcare Conference March 11, 2025 8:00 AM ET Good morning, everyone. My name is Balaji Prasad. I'm the Senior ...
Ahead of the Fourth High-Level Meeting of the UN General Assembly on the prevention and control of NCDs and mental health this September, the global trade association representing the pharmaceutical ...
Unico Global Opportunities Fund Limited acquired ... at Rs 53 per share. Balaxi Pharmaceuticals is an Indian pharmaceutical company that manufactures, sells, and stocks branded and generic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results